FSIPP & FSPMR 2021 Conference

FSIPP  FSPMR 2021 Conference
Details
  • Overview

    Pain management and interventional pain management are quickly growing fields in medicine. Emerging science and treatment options for patient care are growing rapidly and it is important for clinicians specializing in this field of medicine to know, understand and evaluate available options to be able to continue to provide the best treatment options and quality of care for patients. Additionally, this field of medicine is subject to higher than normal scrutiny, liability and litigiousness stemming from alleged over treatment and under treatment of care. It is vitally important for clinicians to understand best practices and practice guidelines to ensure that they are offering the best care, remaining in compliance to lessen exposure and liability while still ensuring access to care and the best treatment outcomes for patients.

    This certified CME activity will unite pain practitioners from across the United States, Europe & Caribbean including; engineers, researchers, anesthesiologists, neurosurgeons, neurologists, pain medicine specialists, and venture capitalists.

    Please click on Begin Course to access your evaluation and certificate.

    Supported by an unrestricted educational grant from Abbott, Boston Scientific, and Medtronic.

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Recognize and evaluate pain, description of pain, and pain markers.
    • Interpret new Federal Regulations to assist in implementing standards of care and to assist in patient and compliance.
    • Achieve a greater understanding of best practices and available guidelines on new techniques, agents and therapies for patients.
    • Accreditation

      Jointly Provided by Evolve Medical Education, LLC and Mantra Meetings. 

             

      This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education, LLC and Mantra Meetings. Evolve Medical Education, LLC is accredited by the ACCME to provide continuing medical education for physicians.
      Physicians
      Evolve Medical Education designates this live activity for a maximum of 18 AMA PRA Category 1 Credit™.
      Physicians should claim only the credit commensurate with the extent of their participation in the activity.
      Nurses
      Evolve Medical Education, LLC is an approved provider by the California Board of Registered Nursing, Provider Number 17004 for 18 contact hours.

    • Participation Method

      In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

      Course Viewing Requirements

      Supported Browsers:
      Internet Explorer 11 for Windows
      Edge (recent versions; Chromium-based) for Windows
      Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
      Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
      Safari (recent versions) for Mac OSX, or iOS

      Hardware Requirements:
      4GB+ RAM
      Recommended internet speed 5Mbps+

    • Faculty and Disclosures

      Miguel de la Garza, MD, DABA, DABPM

      Miguel de la Garza, MD, DABA, DABPM

      Course Director
      Partner
      Comprehensive Pain Management Partners
      New Port Richey, FL


      DISCLOSURE POLICY
      It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.

      The following faculty/staff members have the following financial relationships with commercial interests:

      Miguel de la Garza, MD, DABA, DABPM, has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: BDSI, Baudax Bio, Boston Scientific; Grant/Research Support: Baudax Bio; Speaker's Bureau: BDSI, Baudax Bio, Boston Scientific.

      Humam Akbik, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Stimwave; Speaker's Bureau: Stimwave.

      Edwin Amirianfar, DO, PGY3, has no financial relationships to disclose.

      Ajay Antony, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Boston Scientific, PainTEQ; Grant/Research Support: Abbott, Boston Scientific, Nalu, PainTEQ, SPR Therapeutics.

      Miguel D. Attias, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Speaker's Bureau: Captiva Spine.

      Andrae Bailey has no financial relationships to disclose.

      Robert Ball, DO, MS, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Nevro, Abbott, Vertos Medical; Grant/Research Support: Nalu, Boston Scientific (Vertiflex); Speaker’s Bureau: Abbott, Relievant.

      Ramsin Benyamin, MD, has no financial relationships to disclose.

      Maulik K. Bhalani, MD, has no financial relationships to disclose.

      Judith L. Blaszczyk RN, CPC, ACS-PM, ICDCT-CM, has no financial relationships to disclose.

      Cristina Brea, MD, PGY4, has no financial relationships to disclose.

      Jennifer Bunch, MD, has no financial relationships to disclose.

      Kenneth D. Candido, MD, has no financial relationships to disclose.

      David Caraway, MD, PhD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Employee: Chief Medical Officer, Nevro Corp.

      Christopher J. Centeno, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Shareholder: Regenerative Sciences.

      Kenneth B. Chapman, MD, has no financial relationships to disclose.

      Bella Chokshi, DO, has no financial relationships to disclose.

      Jonathan Daitch, MD, MBA, has no financial relationships to disclose.

      Harold L. Dalton, DO, FAAPM&R, DABPM, has no financial relationships to disclose.

      Miles Day, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Shareholder: Alethiah.

      Miguel de la Garza, MD, DABA, DABPM, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: BDSI, Baudax Bio, Boston Scientific; Grant/Research Support: Baudax Bio; Speaker's Bureau: BDSI, Baudax Bio, Boston Scientific.

      Sudhir Diwan, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Apex Bologix; Shareholder: CornerLoc.

      Brian Durkin, DO, D.ABA, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Vertos Medical, Nevro, Relievant, Avanos.

      Michael F. Esposito, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Boston Scientific, Medtronic, Nevro; Grant/Research Support: Abbott, Boston Scientific, Medtronic, Nevro, CornerLoc; Speaker's Bureau: Abbott, Boston Scientific, Medtronic, Nevro.

      Vania E. Fernandez, MD, has no financial relationships to disclose.

      Joslyn Gober, DO, has no financial relationships to disclose.

      Stanley Golovac, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Vertos Medical, Vivex, Saluda Medical, Abbott; Speaker's Bureau: Vertos Medical, Vivex, Saluda Medical, Abbott.

      Jeffrey Gudin, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: BDSI, Hisamitsu, Scilex, Sanofi, Quest, Versea, XGene; Grant/Research Support: NIH NCATS; Shareholder: Virpax.

      Nirav Gupta, DO, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Speaker's Bureau: Baudax Bio.

      Andres E. Gutierrez Robles, MD, has no financial relationships to disclose.

      Louis M. Guzzi, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Speaker's Bureau: Biomeroeux, Alexion, Lajolla.

      Diana A. Hussain, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Spine and Brain; Grant/Research Support: Spine and Brain.

      Navdeep S. Jassal, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Vertos Medical, Flowonix, Abbott, Boston Scientific, Medtronic, CornerLoc; Grant/Research Support: Flowonix, Vertos Medical; Speaker's Bureau: Vertos Medical, Flowonix, Abbott, Medtronic, CornerLoc.

      Jon Johnson has no financial relationships to disclose.

      Sean Li, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Abbott, Avanos, Biotronik, Boston Scientific, Nalu, Nevro Corp., PainTEQ, Saluda Medical, SI-BONE, SPR Therapeutics, Vertos Medical; Grant/Research Support: Avanos, Biotronik, Boston Scientific, Nevro Corp., Saluda Medical, SGX Medical, SPR Therapeutics; Speaker's Bureau: Gruenthal Pharmaceuticals; Shareholder: Nalu, National Spine and Pain Centers.

      Craig H. Lichtblau, MD, has no financial relationships to disclose.

      Jesse Lipnick, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Vertos Medical.

      Meredith Loveless, MD, FACOG, has no financial relationships to disclose.

      Nagy Mekhail, MD, PhD, has no financial relationships to disclose.

      Richard Morgan, DO, PGY3, has no financial relationships to disclose.

      Robert Mousselli, DO, PGY3, has no financial relationships to disclose.

      George Nassif, Jr., DO, FACS, FASCRS, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Applied Medical; Speaker’s Bureau: Anjeso.

      Kenneth Ngo, MD, has no financial relationships to disclose.

      Quang “Wayne” Nguyen, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Vertos Medical, Omnia Medical, Nevro, NuTech Spine; Grant/Research Support: Vertos Medical.

      Mario M. Paese, DO, PGY3, has no financial relationships to disclose.

      Julio C. Paez, MD, has no financial relationships to disclose.

      Sunil J. Panchal, MD, has no financial relationships to disclose.

      Arpit A. Patel, DO, has no financial relationships to disclose.

      Nileshkumar Patel, MD, MBA, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Chief Medical Officer: Boston Scientific.

      Michael Patete, MD, has no financial relationships to disclose.

      Rene Przkora, MD, PhD, has no financial relationships to disclose.

      Mark Rubenstein, MD, PA, has no financial relationships to disclose.

      Jonas Santos, DO, PGY4, has no financial relationships to disclose.

      Andrew L. Sherman, MD, has no financial relationships to disclose.

      Maurice G. Sholas, MD, PhD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Grant/Research Support: Robert Wood Johnson Foundation; Other Financial/Material Support: Sholas Medical Constulting, LLC.

      Allyson A. Shrikhande, MD, has no financial relationships to disclose.

      Sanford M. Silverman, MD, has no financial relationships to disclose.

      Brian Smith, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Shareholder: Medtronic, Other Financial/Material Support: Medtronic.

      Amol Soin, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Grant/Research Support: Avanos, Neuronoff, Neuros; Shareholder: Neuros, Neuronoff, Soin Neuroscience.

      Peter S. Staats, MD, MBA, FIPP, ABIPP, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: National Spine & Pain Centers; Shareholder: electroCore, National Spine & Pain Centers, Saluda Medical, SPR Therapeutics; Other Financial/Material Support: electroCore.

      Carrie Steichen, DO, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Speaker's Bureau: Boston Scientific.

      Leslie Stevens, MD, has no financial relationships to disclose.

      Patrick J. Tighe, MD, MS, has no financial relationships to disclose.

      Theresa Tolle, BPharm, FAPhA, CPESN, has no financial relationships to disclose.

      Deborah H. Tracy MD, MBA, has no financial relationships to disclose.

      Andrea Trescot, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Other Financial/Material Support: Stimwave Technologies.

      Ricardo Vallejo, MD, PhD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Medtronic; Speaker’s Bureau: Medtronic; Shareholder: SGX-Medical (No Commercial Product).

      Adam J. Woods, PhD, has no financial relationships to disclose.

      Kerstin Yu, MS1, has no financial relationships to disclose.

      Colleen M. Zittel, MD, has no financial relationships to disclose.

      The Evolve staff/planners and Mantra Meetings staff/planners have no financial relationships with commercial interests.

      Deborah H. Tracy MD, MBA, Rene Przkora, MD, PhD, Sanford M. Silverman, MD, and Mark Rubenstein, MD, PA, peer reviewers, have no financial relationships with commercial interests.

    • Disclaimer

      OFF-LABEL STATEMENT
      This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

      DISCLAIMER
      The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Mantra Meetings, the Florida Society of Interventional Pain Physicians (FSIPP), the Florida Society of Physical Medicine and Rehabilitation (FSPM&R), Abbott, Boston Scientific, or Medtronic.

    • System Requirements

      • Supported Browsers (2 most recent versions):
        • Google Chrome for Windows, Mac OS, iOS, and Android
        • Apple Safari for Mac OS and iOS
        • Mozilla Firefox for Windows, Mac OS, iOS, and Android
        • Microsoft Edge for Windows
      • Recommended Internet Speed: 5Mbps+

    • Publication Dates

      Expiration Date:

    18.00 credits
    Completing the pre-test is required to access this content.
    Completing the pre-survey is required to view this content.

    Ready to Claim Your Credits?

    You have attempts to pass this post-test. Take your time and review carefully before submitting.

    Good luck!

    Register

    We're glad to see you're enjoying Evolve Medical Education…
    but how about a more personalized experience?

    Register for free